These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 34975712)
61. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome. Odaka M; Yuki N; Hirata K J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908 [TBL] [Abstract][Full Text] [Related]
62. Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison. Vanhoutte EK; Draak TH; Gorson KC; van Nes SI; Hoeijmakers JG; Van der Pol WL; Notermans NC; Lewis RA; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS; J Peripher Nerv Syst; 2015 Sep; 20(3):289-95. PubMed ID: 26114893 [TBL] [Abstract][Full Text] [Related]
63. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis]. Irie S; Saito T; Kanazawa N; Ito H; Kowa H Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057 [TBL] [Abstract][Full Text] [Related]
65. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS). van Doorn PA Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447 [TBL] [Abstract][Full Text] [Related]
66. New chronic inflammatory demyelinating polyneuropathy/Guillain-Barré syndrome guidelines - impact on clinical practise. Allen JA Curr Opin Neurol; 2024 Oct; 37(5):455-460. PubMed ID: 38873801 [TBL] [Abstract][Full Text] [Related]
67. Intravenous immunoglobulin and plasma exchange prescribing patterns for Guillain-Barre Syndrome in the United States-2001 to 2018. Stino AM; Reynolds EL; Watanabe M; Callaghan BC Muscle Nerve; 2024 Sep; ():. PubMed ID: 39324188 [TBL] [Abstract][Full Text] [Related]
68. Treatment of Guillain-Barré syndrome and CIDP. van Doorn PA J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124 [TBL] [Abstract][Full Text] [Related]
69. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128 [TBL] [Abstract][Full Text] [Related]
70. Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient. Castellazzi M; Morotti A; Tamborino C; Alessi F; Pilotto S; Baldi E; Caniatti LM; Trentini A; Casetta I; Granieri E; Pugliatti M; Fainardi E; Bellini T Fluids Barriers CNS; 2020 Feb; 17(1):14. PubMed ID: 32024544 [TBL] [Abstract][Full Text] [Related]
71. Chronic inflammatory demyelinating polyneuropathy and HEV antibody status: A case-control study from Lazio, Italy. Moret F; Spada E; Ceccanti M; Libonati L; D'Andrea E; Villano U; Madonna E; Chionne P; Carocci A; Pisani G; Fionda L; Antonini G; Petrucci A; Bruni R; Ciccaglione AR; Taliani G; Rivano Capparuccia M; Nobile-Orazio E; Inghilleri M; Cambieri C J Neurol Sci; 2024 Apr; 459():122959. PubMed ID: 38490091 [TBL] [Abstract][Full Text] [Related]